[1] |
HERNAEZ R, SOLÀ E, MOREAU R, et al. Acute-on-chronic liver failure: an update[J]. Gut, 2017, 66(3): 541-553. DOI: 10.1136/gutjnl-2016-312670.
|
[2] |
KHANAM A, KOTTILIL S. Acute-on-chronic liver failure: pathophysiological mechanisms and management[J]. Front Med (Lausanne), 2021, 8: 752875. DOI: 10.3389/fmed.2021.752875.
|
[3] |
孙梦滢, 陈备金, 李浩, 等. 晚期乙型肝炎相关慢加急性肝衰竭患者预后相关因素分析[J]. 中华肝脏病杂志, 2021, 29(10): 983-986. DOI: 10.3760/cma.j.cn501113-20200630-00354.SUN MY, CHEN BJ, LI H, et al. Analysis of prognosis-related factors in patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Chin J Hepatol, 2021, 29(10): 983-986. DOI: 10.3760/cma.j.cn501113-20200630-00354.
|
[4] |
JALAN R, GUSTOT T, FERNANDEZ J, et al. 'Equity' and 'Justice' for patients with acute-on chronic liver failure: a call to action[J]. J Hepatol, 2021, 75(5): 1228-1235. DOI: 10.1016/j.jhep.2021.06.017.
|
[5] |
ABDALLAH MA, KUO YF, ASRANI S, et al. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality[J]. J Hepatol, 2021, 74(6): 1355-1361. DOI: 10.1016/j.jhep.2020.12.003.
|
[6] |
李郑红, 董育玮, 陆伦根. 肝肾综合征发生的危险因素、诊断和最新分型[J]. 临床肝胆病杂志, 2020, 36(11): 2411-2414. DOI: 10.3969/j.issn.1001-5256.2020.11.003.LI ZH, DONG YW, LU LG. Risk factors, diagnosis, and updated classification of hepatorenal syndrome[J]. J Clin Hepatol, 2020, 36(11): 2411-2414. DOI: 10.3969/j.issn.1001-5256.2020.11.003.
|
[7] |
BIGGINS SW, KIM WR, TERRAULT NA, et al. Evidence-based incorporation of serum sodium concentration into MELD[J]. Gastroenterology, 2006, 130(6): 1652-1660. DOI: 10.1053/j.gastro.2006.02.010.
|
[8] |
韩成美, 任运华, 丁雷. COSSH-ACLF评分联合血清白细胞介素-37水平对乙型肝炎病毒相关慢加急性肝衰竭患者近期预后的评估价值[J]. 实用医学杂志, 2021, 37(4): 472-476. DOI: 10.3969/j.issn.1006-5725.2021.04.011.HAN CM, REN YH, DING L. The evaluation value of COSSH-ACLF score combined with serum IL-37 level in short-term prognosis of patients with chronic hepatitis B Virus (HBV) associated with acute liver failure[J]. J Pract Med, 2021, 37(4): 472-476. DOI: 10.3969/j.issn.1006-5725.2021.04.011.
|
[9] |
ZHENG MH, SHI KQ, FAN YC, et al. A model to determine 3-month mortality risk in patients with acute-on-chronic hepatitis B liver failure[J]. Clin Gastroenterol Hepatol, 2011, 9(4): 351-356. DOI: 10.1016/j.cgh.2010.12.027.
|
[10] |
XIA Q, DAI X, ZHANG Y, et al. A modified MELD model for Chinese pre-ACLF and ACLF patients and it reveals poor prognosis in pre-ACLF patients[J]. PLoS One, 2013, 8(6): e64379. DOI: 10.1371/journal.pone.0064379.
|
[11] |
ARTZNER T, MICHARD B, WEISS E, et al. Liver transplantation for critically ill cirrhotic patients: stratifying utility based on pretransplant factors[J]. Am J Transplant, 2020, 20(9): 2437-2448. DOI: 10.1111/ajt.15852.
|
[12] |
BURRA P, SAMUEL D, SUNDARAM V, et al. Limitations of current liver donor allocation systems and the impact of newer indications for liver transplantation[J]. J Hepatol, 2021, 75 (Suppl 1): S178-S190. DOI: 10.1016/j.jhep.2021.01.007.
|
[13] |
LINECKER M, KRONES T, BERG T, et al. Potentially inappropriate liver transplantation in the era of the "sickest first" policy - a search for the upper limits[J]. J Hepatol, 2018, 68(4): 798-813. DOI: 10.1016/j.jhep.2017.11.008.
|
[14] |
LEVESQUE E, WINTER A, NOORAH Z, et al. Impact of acute-on-chronic liver failure on 90-day mortality following a first liver transplantation[J]. Liver Int, 2017, 37(5): 684-693. DOI: 10.1111/liv.13355.
|
[15] |
ARTRU F, LOUVET A, RUIZ I, et al. Liver transplantation in the most severely ill cirrhotic patients: a multicenter study in acute-on-chronic liver failure grade 3[J]. J Hepatol, 2017, 67(4): 708-715. DOI: 10.1016/j.jhep.2017.06.009.
|
[16] |
THULUVATH PJ, THULUVATH AJ, SAVVA Y, et al. Karnofsky performance status following liver transplantation in patients with multiple organ failures and probable acute-on-chronic liver failure[J]. Clin Gastroenterol Hepatol, 2020, 18(1): 234-241. DOI: 10.1016/j.cgh.2019.03.016.
|
[17] |
WEISS E, SANER F, ASRANI SK, et al. When is a critically ill cirrhotic patient too sick to transplant? development of consensus criteria by a multidisciplinary panel of 35 international experts[J]. Transplantation, 2021, 105(3): 561-568. DOI: 10.1097/TP.0000000000003364.
|
[18] |
ABDALLAH MA, WALEED M, BELL MG, et al. Systematic review with Meta-analysis: liver transplant provides survival benefit in patients with acute on chronic liver failure[J]. Aliment Pharmacol Ther, 2020, 52(2): 222-232. DOI: 10.1111/apt.15793.
|
[19] |
ZACCHERINI G, WEISS E, MOREAU R. Acute-on-chronic liver failure: definitions, pathophysiology and principles of treatment[J]. JHEP Rep, 2020, 3(1): 100176. DOI: 10.1016/j.jhepr.2020.100176.
|
[20] |
SU H, TONG J, LIU X, et al. Characteristics and outcome of nosocomial bloodstream infection in patients with acute-on-chronic liver failure[J]. Eur J Gastroenterol Hepatol, 2021, 33(1): 83-88. DOI: 10.1097/MEG.0000000000001699.
|
[21] |
ALSHAMSI F, ALSHAMMARI K, BELLEY-COTE E, et al. Extracorporeal liver support in patients with liver failure: a systematic review and Meta-analysis of randomized trials[J]. Intensive Care Med, 2020, 46(1): 1-16. DOI: 10.1007/s00134-019-05783-y.
|
[22] |
CHANCHAROENTHANA W, LEELAHAVANICHKUL A. Acute kidney injury spectrum in patients with chronic liver disease: where do we stand?[J]. World J Gastroenterol, 2019, 25(28): 3684-3703. DOI: 10.3748/wjg.v25.i28.3684.
|
[23] |
KARVELLAS CJ, TAYLOR S, BIGAM D, et al. Intraoperative continuous renal replacement therapy during liver transplantation: a pilot randomized-controlled trial (INCEPTION)[J]. Can J Anaesth, 2019, 66(10): 1151-1161. DOI: 10.1007/s12630-019-01454-0.
|
[24] |
中华医学会器官移植学分会围手术期管理学组. 肝衰竭肝移植围手术期管理中国专家共识(2021版)[J]. 中华消化外科杂志, 2021, 20(8): 835-840. DOI: 10.3760/cma.j.cn115610-20210626-00312.Perioperative Management Group of Organ Transplantation Branch of Chinese Medical Association. Chinese expert consensus on perioperative management of liver transplantation in patients with liver failure (2021 edition)[J]. Chin J Dig Surg, 2021, 20(8): 835-840. DOI: 10.3760/cma.j.cn115610-20210626-00312.
|
[25] |
吴若林, 赵红川, 耿小平. 肝移植治疗成人慢加急性肝功能衰竭的现状[J]. 中华外科杂志, 2022, 60(2): 182-188. DOI: 10.3760/cma.j.cn112139-20210810-00369.WU RL, ZHAO HC, GENG XP. Current status of liver transplantation for adult patients with acute-on-chronic liver failure[J]. Chin J Surg, 2022, 60(2): 182-188. DOI: 10.3760/cma.j.cn112139-20210810-00369.
|
[26] |
TEEGEN EM, MAURER MM, GLOBKE B, et al. Liver transplantation for Hepatitis-B-associated liver disease - three decades of experience[J]. Transpl Infect Dis, 2019, 21(1): e12997. DOI: 10.1111/tid.12997.
|
[27] |
BHATTI ABH, DAR FS, BUTT MO, et al. Living donor liver transplantation for acute on chronic liver failure based on EASL-CLIF diagnostic criteria[J]. J Clin Exp Hepatol, 2018, 8(2): 136-143. DOI: 10.1016/j.jceh.2017.11.007.
|
[28] |
GOUSSOUS N, XIE W, ZHANG T, et al. Acute on chronic liver failure: resource utilization and predictors for liver transplantation[J]. Am J Transplant, 2021, 21(S1): 36.
|
[29] |
MACCONMARA M, HANISH SI, HWANG CS, et al. Making every liver count: increased transplant yield of donor livers through normothermic machine perfusion[J]. Ann Surg, 2020, 272(3): 397-401. DOI: 10.1097/SLA.0000000000004198.
|
[30] |
ENGELMANN C, HERBER A, FRANKE A, et al. Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: a multicenter randomized trial (GRAFT study)[J]. J Hepatol, 2021, 75(6): 1346-1354. DOI: 10.1016/j.jhep.2021.07.033.
|
[31] |
ZHU B, YOU S, RONG Y, et al. A novel stem cell therapy for hepatitis B virus-related acute-on-chronic liver failure[J]. Braz J Med Biol Res, 2020, 53(11): e9728. DOI: 10.1590/1414-431X20209728.
|
[32] |
ALHOMRANI M, CORREIA J, ZAVOU M, et al. The human amnion epithelial cell secretome decreases hepatic fibrosis in mice with chronic liver fibrosis[J]. Front Pharmacol, 2017, 8: 748. DOI: 10.3389/fphar.2017.00748.
|